| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,010,000 | 2,002,000 | 1,977,000 | 2,025,000 | | Cost of Revenue | 607,000 | 630,000 | 654,000 | 605,000 | | | Gross Profit | 1,403,000 | 1,372,000 | 1,323,000 | 1,420,000 | | | Operating Expenses | | Research Development | 257,000 | 257,000 | 223,000 | 269,000 | | Selling General and Administrative | 697,000 | 766,000 | 660,000 | 702,000 | | Non Recurring | 310,000 | 2,633,000 | 280,000 | 10,000 | | Others | 128,000 | 133,000 | 131,000 | 136,000 | | | | Total Operating Expenses | 1,392,000 | 3,789,000 | 1,294,000 | 1,117,000 | | | | Operating Income or Loss | 11,000 | (2,417,000) | 29,000 | 303,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,000) | (1,000) | 15,000 | (85,000) | | Earnings Before Interest And Taxes | 5,000 | (2,418,000) | 44,000 | 218,000 | | Interest Expense | 102,000 | 107,000 | 112,000 | 118,000 | | Income Before Tax | (97,000) | (2,525,000) | (68,000) | 100,000 | | Income Tax Expense | (84,000) | (131,000) | (6,000) | 2,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,000) | (2,394,000) | (62,000) | 98,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,000) | (2,394,000) | (62,000) | 98,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,000) | ($2,394,000) | ($62,000) | $98,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
